The Current Ratio as of November 2024 (TTM) for ReShape Lifesciences Inc. (RSLS) is 1.90

According to ReShape Lifesciences Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.90. This represents a change of -10.79% compared to the average of 2.13 of the last 4 quarters.

ReShape Lifesciences Inc. (RSLS) Historical Current Ratio (quarterly & annually)

How has RSLS Current Ratio performed in the past?

The mean historical Current Ratio of ReShape Lifesciences Inc. over the last ten years is 3.43. The current 1.90 Current Ratio has changed 5.44% with respect to the historical average. Over the past ten years (40 quarters), RSLS's Current Ratio was at its highest in in the December 2017 quarter at 12.81. The Current Ratio was at its lowest in in the September 2018 quarter at 0.30.

ReShape Lifesciences Inc. (RSLS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of ReShape Lifesciences Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ReShape Lifesciences Inc. (RSLS) Average Current Ratio

How has RSLS Current Ratio performed in the past?

The current Current Ratio of ReShape Lifesciences Inc. (RSLS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ReShape Lifesciences Inc. (RSLS) Current Ratio vs. Peers

How is RSLS’s Current Ratio compared to its peers?

ReShape Lifesciences Inc.’s Current Ratio is less than Sintx Technologies, Inc. (1.94), less than Bone Biologics Corporation (11.22), less than Ra Medical Systems, Inc. (2.84), less than Tivic Health Systems, Inc. (7.89), greater than Nuwellis, Inc. (1.20), less than Talis Biomedical Corporation (7.76), greater than Tenon Medical, Inc. (1.20), greater than INVO Bioscience, Inc. (0.30), less than Helius Medical Technologies, Inc. (4.20), less than Heart Test Laboratories, Inc. (4.49), less than NeuroMetrix, Inc. (11.62), less than Inspira Technologies Oxy B.H.N. Ltd. (2.61), greater than OpGen, Inc. (0.05),

Build a custom stock screener for ReShape Lifesciences Inc. (RSLS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ReShape Lifesciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ReShape Lifesciences Inc. (RSLS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ReShape Lifesciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.